Abstract
Objective
Chylothorax is a rare but life-threatening condition in children. To date, there is no commonly accepted treatment protocol. Somatostatin and octreotide have recently been used for treating chylothorax in children. We set out to summarise the evidence on the efficacy and safety of somatostatin and octreotide in treating young children with chylothorax.
Design
Systematic review: literature search (Cochrane Library, EMBASE and PubMed databases) and literature hand search of peer reviewed articles on the use of somatostatin and octreotide in childhood chylothorax.
Patients
Thirty-five children treated for primary or secondary chylothorax (10/somatostatin, 25/octreotide) were found.
Results
Ten of the 35 children had been given somatostatin, as i.v. infusion at a median dose of 204 μg/kg/day, for a median duration of 9.5 days. The remaining 25 children had received octreotide, either as an i.v. infusion at a median dose of 68 μg/kg/day over a median 7 days, or s.c. at a median dose of 40 μg/kg/day and a median duration of 17 days. Side effects such as cutaneous flush, nausea, loose stools, transient hypothyroidism, elevated liver function tests and strangulation-ileus (in a child with asplenia syndrome) were reported for somatostatin; transient abdominal distension, temporary hyperglycaemia and necrotising enterocolitis (in a child with aortic coarctation) for octreotide.
Conclusions
A positive treatment effect was evident for both somatostatin and octreotide in the majority of reports. Minor side effects have been reported, however caution should be exercised in patients with an increased risk of vascular compromise as to avoid serious side effects. Systematic clinical research is needed to establish treatment efficacy and to develop a safe treatment protocol.
Similar content being viewed by others
Abbreviations
- AVC:
-
atrio-ventricular canal
- CHD:
-
congenital heart disease
- GA:
-
gestational age
- i.v.:
-
intravenous
- NEC:
-
necrotising enterocolitis
- OCT:
-
octreotide
- POD:
-
postoperative day
- s.c.:
-
subcutaneous
- SST:
-
somatostatin
- TAPVC:
-
total anomalous pulmonary venous connection
References
Buttiker V, Fanconi S, Burger R (1999) Chylothorax in children: guidelines for diagnosis and management. Chest 116:682–687
van Straaten HL, Gerards LJ, Krediet TG (1993) Chylothorax in the neonatal period. Eur J Pediatr 152:2–5
Efrati O, Barak A (2002) Pleural effusions in the pediatric population. Pediatr Rev 12:417–426
Dubin PJ, King IN, Gallagher PG (2000) Congenital chylothorax. Curr Opin Pediatr 12:505–509
Beghetti M, La Scala G, Belli D, Bugmann P, Kalangos A, Le Coultre C (2000) Etiology and management of pediatric chylothorax. J Pediatr 136:653–658
Hagay Z, Reece A, Roberts A, Hobbins JC (1993) Isolated fetal pleural effusion: a prenatal management dilemma. Obstet Gynecol 81:147–152
Bessone LN, Ferguson TB, Burford TH (1971) Chylothorax. Ann Thorac Surg 12: 527–550
Chernick V, Reed MH (1970) Pneumothorax and chylothorax in the neonatal period. J Pediatr 76:624–632
van Aerde J, Campbell AN, Smyth JA, Lloyd D, Bryan MH (1984) Spontaneous chylothorax in newborns. AJDC 138:961–964
Cormack BE, Wilson NJ, Finucane K, West TM (2004) Use of Monogen for pediatric postoperative chylothorax. Ann Thorac Surg 77:301–305
Romero S (2000) Nontraumatic chylothorax. Curr Opin Pulm Med 6:287–291
Puntis JW, Roberts KD, Handy D (1987) How should chylothorax be managed? Arch Dis Child 62:593–596
Wasmuth-Pietzuch A, Hansmann M, Bartmann P, Heep A (2004) Congenital chylothorax: lymphopenia and high risk of neonatal infections. Acta Paediatr 93:220–224
Seneff MG, Corwin RW, Gold LH, Irwin RS (1986) Complications associated with thoracocentesis. Chest 90:97–100
Fernandez Alvarez JR, Kalache KD, Grauel EL (1999) Management of spontaneous congenital chylothorax: oral medium-chain triglycerides versus total parenteral nutrition. Am J Perinatol 16:415–420
Mussat P, Dommergues M, Parat S, Mandelbrot L, de Gamarra E, Dumez Y, Moriette G (1995) Congenital chylothorax with hydrops: postnatal care and outcome following antenatal diagnosis. Acta Paediatr 84:749–755
Mohan H, Paes ML, Haynes S (1999) Use of intravenous immunoglobulins as an adjunct in the conservative management of chylothorax. Paediatr Anaesth 9: 89–92
Brissaud O, Desfrere L, Mohsen R, Fayon M, Demarquez JL (2003) Congenital idiopathic chylothorax in neonates: chemical pleurodesis with povidone-iodine (Betadine). Arch Dis Child Fetal Neonatal Ed 88:F531–533
Al-Tawil K, Ahmed G, Al-Hathal M, Al-Jarallah Y, Campbell N (2000) Congenital chylothorax. Am J Perinatol 17:121–126
Rimensberger PC, Muller-Schenker B, Kalangos A, Beghetti M (1998) Treatment of a persistent postoperative chylothorax with somatostatin. Ann Thorac Surg 66:253–254
Cheung Y, Leung MP, Yip M (2001) Octreotide for treatment of postoperative chylothorax. J Pediatr 139:157–159
Cochrane Library: http://www.update-software.com/clibng/cliblogon.htm. Accessed 25.05.2005
EMBASE: http://web5.silverplatter.com/webspirs.ws. Accessed 25.05.2005
Pubmed: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding = idecuhmlib. Accessed 25.05.2005
Philips B, Ball C, Sackett D, Badenough D, Straus S, Dawes M. http://www.cebm.net/levels_of_evidence.asp . Accesed 25.05.2005
Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283:2008–2012
Clarke SA, Lakhoo K, Sherwood W (2005) Somatostatin for intractable postoperative chylothorax in a premature infant. Pediatr Surg Int 21: 390–391
Matsuo T, Matsumoto M, Sugita T (2003) Treatment of persistent chylothorax with somatostatin. Ann Thorac Surg 76:340–341
Pettitt TW, Caspi J, Borne A (2002) Treatment of persistent chylothorax after Norwood procedure with somatostatin. Ann Thorac Surg 73:977–979
Buettiker V, Hug MI, Burger R, Baenziger O (2001) Somatostatin: a new therapeutic option for the treatment of chylothorax. Intensive Care Med 27: 1083–1086
Markham KM, Glover JL, Welsh RJ, Lucas RJ, Bendick PJ (2000) Octreotide in the treatment of thoracic duct injuries. Am Surg 66:1165–1167
Roehr CC, Jung A, Curcin OA, Proquitte H, Hammer H, Wauer R (2005) Loculated neonatal chylothorax treated with Octreotide: complete recovery whilst on unrestricted full fat breast milk. Ann Thorac Surg 80:1981–1982
Mohseni-Bod H, Macrae D, Slavik Z (2004) Somatostatin analog (octreotide) in management of neonatal postoperative chylothorax: Is it safe? Pediatr Crit Care Med 5:356–357
Hamdan MA, Gaeta ML (2004) Octreotide and low-fat breast milk in postoperative chylothorax. Ann Thorac Surg 77:2215–2217
Tibballs J, Soto R, Bharucha T (2004) Management of newborn lymphangiectasia and chylothorax after cardiac surgery with octreotide infusion. Ann Thorac Surg 77:2213–2215
Lam JC, Aters S, Tobias JD (2001) Initial experience with octreotide in the pediatric population. Am J Ther 8:409–415
Al-Zubairy SA (2003) Octreotide as a therapeutic option for management of chylothorax. Ann Pharm 37:679–682
Pratap U, Slavik Z, Ofoe VD, Onuzo O, Franklin RC (2001) Octreotide to treat postoperative chylothorax after cardiac operations in children. Ann Thorac Surg 72:1740–1742
Rosti L, Bini RM, Chessa M, Somato G, Drago M, Carminati M (2002) The effectiveness of octreotide in the treatment of post-operative chylothorax. Eur J Pediatr 161:149–150
Goyal A, Smith NP, Jesudason EC, Kerr S, Losty P (2003) Octreotide for treatment of chylothorax after repair of congenital diaphragmatic hernia. J Pediatr Surg 38:E32
Aleo Lujan E, Uran Moreno MM, Brandstrup Azuero KB, Lopez-Herce Cid J, Zunzunegui Martinez JL (2003) Octreotide treatment of post surgical chylothorax. An Pediatr (Barc) 58:390–392
Au M, Weber TR, Fleming RE (2003) Successful use of Somatostatin in a case of neonatal chylothorax. J Pediatr Surg 38:1106–1107
Goto M, Kawamata K, Kitano M (2003)Treatment of chylothorax in a premature infant using Somatostatin. J Perinatol 23:563–564
Coulter DM (2004) Successful treatment with octreotide of spontaneous chylothorax in a premature infant. J Perinatol 24:194–195
Sivasli E, Dogru D, Tana Aslan A, Yurdakok M, Tekinalp G (2004) Spontaneous neonatal chylothorax treated with octreotide in Turkey: a case report. J Perinatol 24:261–262
Young S, Dalgleish S, Eccleston A, Akierman A, McMillan D (2004) Severe congenital chylothorax treated with octreotide. J Perinatol 24:200–202
Rasiah SV, Oei J, Lui K (2004) Octreotide in the treatment of congenital chylothorax. J Paediatr Child Health 40:585–588
Lauterbach R, Sczaniecka B, Koziol J, Knapczyk M (2005) Somatostatin treatment of spontaneous chylothorax in an extremely low birth weight infant. Eur J Pediatr 164:195–196
Ottinger J (2002)Octreotide for persistent chylothorax in a paediatric patient. Ann Pharmacother 36:1106–1107
Maayan-Metzger A, Sack J, Mazkereth R, Kuint J (2005) Somatostatin treatment of congenital chylotothrax may induce transient hypothyroidism newborns. Acta Paediatr 94:785–789
Leelahanon S, Petlek W, Sontimuang W, Pochanart P, Tepakorn V, Ruangpeg S (2003) Can octreotide be the first line treatment for chylothorax? J Med Assoc Thai 86 Suppl 3:S741–745
Ziedalski TM, Raffin TA, Sze DY, Mitchell JD, Robbins RC, Theodore J, Faul JL (2004) Chylothorax after heart/lung transplantation. J Heart Lung Transplant 23:627–631
Lamberts SW, van der Lely AJ, de Herder WW, Hofland LJ (1996) Octreotide. N Engl J Med 334:246–254
Tauber MT, Harris AG, Rochiccioli P (1994) Clinical use of the long acting somatostatin analogue octreotide in pediatrics. Eur J Pediatr 153:304–310
Glaser B, Hirsch HJ, Landau H (1993) Persistent hyperinsulinemic hypoglycemia of infancy: long-term octreotide treatment without pancreatectomy. J Pediatr 123:644–650
Ditchfield MR, Hutson JM (1998) Intestinal rotational abnormalities in polysplenia and asplenia syndromes. Pediatr Radiol 28:303–306
Arevalo RP, Bullabh P, Krauss AN, Auld PA, Spigland N (2003) Octreotide-induced hypoxemia and pulmonary hypertension in premature neonates. J Pediatr Surg 38:251–253
Radetti G, Gentili L, Paganini C, Messner H (2000) Chloelithiasis in a newborn following treatment with the somatostatin analogue octreotide. Eur J Pediatr 159:550
Acknowledgements
We would like to thank Dr. Julia Kresing for translating the Spanish article into German and Ms Jessica Blank for helping with the extensive literature search.
Author information
Authors and Affiliations
Corresponding author
Additional information
No funding was provided for the review, there were no conflicting interests.
Rights and permissions
About this article
Cite this article
Roehr, C.C., Jung, A., Proquitté, H. et al. Somatostatin or octreotide as treatment options for chylothorax in young children: a systematic review. Intensive Care Med 32, 650–657 (2006). https://doi.org/10.1007/s00134-006-0114-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-006-0114-9